Global Pharmacokinetic Testing Market Growth (Status and Outlook) 2025-2031

June 2025 | 82 pages | ID: GEFA026257F4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global DSA Imaging Operating Bed market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

As vascular interventional surgery continues to become more popular, the demand for DSA imaging operating beds is also increasing. The DSA imaging operating bed can provide high-definition angiography images to help doctors diagnose and formulate surgical plans more accurately, thereby improving the accuracy and safety of surgery. In the future, with the widespread application of vascular interventional surgeries, the market demand for DSA imaging operating beds will continue to increase.

LP Information, Inc. (LPI) ' newest research report, the “DSA Imaging Operating Bed Industry Forecast” looks at past sales and reviews total world DSA Imaging Operating Bed sales in 2024, providing a comprehensive analysis by region and market sector of projected DSA Imaging Operating Bed sales for 2025 through 2031. With DSA Imaging Operating Bed sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DSA Imaging Operating Bed industry.

This Insight Report provides a comprehensive analysis of the global DSA Imaging Operating Bed landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DSA Imaging Operating Bed portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global DSA Imaging Operating Bed market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DSA Imaging Operating Bed and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DSA Imaging Operating Bed.

This report presents a comprehensive overview, market shares, and growth opportunities of DSA Imaging Operating Bed market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Flat-Panel DSA Angiography Operating Table
• Suspended DSA Angiography Operating Table

Segmentation by Application:

• Operating Room
• ICU

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AADCO Medical
• ALVO Medical
• BIODEX
• Infimed
• Infinium
• Mizuho OSI
• Medifa
• Schaerer
• Allengers
• Ima-x

Key Questions Addressed in this Report

What is the 10-year outlook for the global DSA Imaging Operating Bed market?

What factors are driving DSA Imaging Operating Bed market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do DSA Imaging Operating Bed market opportunities vary by end market size?

How does DSA Imaging Operating Bed break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pharmacokinetic Testing Market Size (2020-2031)
  2.1.2 Pharmacokinetic Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Pharmacokinetic Testing by Country/Region (2020, 2024 & 2031)
2.2 Pharmacokinetic Testing Segment by Type
  2.2.1 Oral Dissolution Testing (FDC)
  2.2.2 Intravenous Titration Test (IVRT)
  2.2.3 Cell Line In-house Testing (ICR)
2.3 Pharmacokinetic Testing Market Size by Type
  2.3.1 Pharmacokinetic Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
2.4 Pharmacokinetic Testing Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Research Institutions
2.5 Pharmacokinetic Testing Market Size by Application
  2.5.1 Pharmacokinetic Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)

3 PHARMACOKINETIC TESTING MARKET SIZE BY PLAYER

3.1 Pharmacokinetic Testing Market Size Market Share by Player
  3.1.1 Global Pharmacokinetic Testing Revenue by Player (2020-2025)
  3.1.2 Global Pharmacokinetic Testing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmacokinetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PHARMACOKINETIC TESTING BY REGION

4.1 Pharmacokinetic Testing Market Size by Region (2020-2025)
4.2 Global Pharmacokinetic Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmacokinetic Testing Market Size Growth (2020-2025)
4.4 APAC Pharmacokinetic Testing Market Size Growth (2020-2025)
4.5 Europe Pharmacokinetic Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmacokinetic Testing Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Pharmacokinetic Testing Market Size by Country (2020-2025)
5.2 Americas Pharmacokinetic Testing Market Size by Type (2020-2025)
5.3 Americas Pharmacokinetic Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pharmacokinetic Testing Market Size by Region (2020-2025)
6.2 APAC Pharmacokinetic Testing Market Size by Type (2020-2025)
6.3 APAC Pharmacokinetic Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pharmacokinetic Testing Market Size by Country (2020-2025)
7.2 Europe Pharmacokinetic Testing Market Size by Type (2020-2025)
7.3 Europe Pharmacokinetic Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pharmacokinetic Testing by Region (2020-2025)
8.2 Middle East & Africa Pharmacokinetic Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmacokinetic Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PHARMACOKINETIC TESTING MARKET FORECAST

10.1 Global Pharmacokinetic Testing Forecast by Region (2026-2031)
  10.1.1 Global Pharmacokinetic Testing Forecast by Region (2026-2031)
  10.1.2 Americas Pharmacokinetic Testing Forecast
  10.1.3 APAC Pharmacokinetic Testing Forecast
  10.1.4 Europe Pharmacokinetic Testing Forecast
  10.1.5 Middle East & Africa Pharmacokinetic Testing Forecast
10.2 Americas Pharmacokinetic Testing Forecast by Country (2026-2031)
  10.2.1 United States Market Pharmacokinetic Testing Forecast
  10.2.2 Canada Market Pharmacokinetic Testing Forecast
  10.2.3 Mexico Market Pharmacokinetic Testing Forecast
  10.2.4 Brazil Market Pharmacokinetic Testing Forecast
10.3 APAC Pharmacokinetic Testing Forecast by Region (2026-2031)
  10.3.1 China Pharmacokinetic Testing Market Forecast
  10.3.2 Japan Market Pharmacokinetic Testing Forecast
  10.3.3 Korea Market Pharmacokinetic Testing Forecast
  10.3.4 Southeast Asia Market Pharmacokinetic Testing Forecast
  10.3.5 India Market Pharmacokinetic Testing Forecast
  10.3.6 Australia Market Pharmacokinetic Testing Forecast
10.4 Europe Pharmacokinetic Testing Forecast by Country (2026-2031)
  10.4.1 Germany Market Pharmacokinetic Testing Forecast
  10.4.2 France Market Pharmacokinetic Testing Forecast
  10.4.3 UK Market Pharmacokinetic Testing Forecast
  10.4.4 Italy Market Pharmacokinetic Testing Forecast
  10.4.5 Russia Market Pharmacokinetic Testing Forecast
10.5 Middle East & Africa Pharmacokinetic Testing Forecast by Region (2026-2031)
  10.5.1 Egypt Market Pharmacokinetic Testing Forecast
  10.5.2 South Africa Market Pharmacokinetic Testing Forecast
  10.5.3 Israel Market Pharmacokinetic Testing Forecast
  10.5.4 Turkey Market Pharmacokinetic Testing Forecast
10.6 Global Pharmacokinetic Testing Forecast by Type (2026-2031)
10.7 Global Pharmacokinetic Testing Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Pharmacokinetic Testing Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pharmaceutical Product Development, LLC
  11.1.1 Pharmaceutical Product Development, LLC Company Information
  11.1.2 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Offered
  11.1.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pharmaceutical Product Development, LLC Main Business Overview
  11.1.5 Pharmaceutical Product Development, LLC Latest Developments
11.2 Charles River Laboratories International, Inc.
  11.2.1 Charles River Laboratories International, Inc. Company Information
  11.2.2 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Offered
  11.2.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Charles River Laboratories International, Inc. Main Business Overview
  11.2.5 Charles River Laboratories International, Inc. Latest Developments
11.3 Creative Bioarray
  11.3.1 Creative Bioarray Company Information
  11.3.2 Creative Bioarray Pharmacokinetic Testing Product Offered
  11.3.3 Creative Bioarray Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Creative Bioarray Main Business Overview
  11.3.5 Creative Bioarray Latest Developments
11.4 Certara, L.P.
  11.4.1 Certara, L.P. Company Information
  11.4.2 Certara, L.P. Pharmacokinetic Testing Product Offered
  11.4.3 Certara, L.P. Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Certara, L.P. Main Business Overview
  11.4.5 Certara, L.P. Latest Developments
11.5 Evotec AG
  11.5.1 Evotec AG Company Information
  11.5.2 Evotec AG Pharmacokinetic Testing Product Offered
  11.5.3 Evotec AG Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Evotec AG Main Business Overview
  11.5.5 Evotec AG Latest Developments
11.6 Pacific BioLabs
  11.6.1 Pacific BioLabs Company Information
  11.6.2 Pacific BioLabs Pharmacokinetic Testing Product Offered
  11.6.3 Pacific BioLabs Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pacific BioLabs Main Business Overview
  11.6.5 Pacific BioLabs Latest Developments
11.7 GVK Biosciences Private Limited
  11.7.1 GVK Biosciences Private Limited Company Information
  11.7.2 GVK Biosciences Private Limited Pharmacokinetic Testing Product Offered
  11.7.3 GVK Biosciences Private Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 GVK Biosciences Private Limited Main Business Overview
  11.7.5 GVK Biosciences Private Limited Latest Developments
11.8 SGS SA
  11.8.1 SGS SA Company Information
  11.8.2 SGS SA Pharmacokinetic Testing Product Offered
  11.8.3 SGS SA Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 SGS SA Main Business Overview
  11.8.5 SGS SA Latest Developments
11.9 LGC Limited
  11.9.1 LGC Limited Company Information
  11.9.2 LGC Limited Pharmacokinetic Testing Product Offered
  11.9.3 LGC Limited Pharmacokinetic Testing Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 LGC Limited Main Business Overview
  11.9.5 LGC Limited Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pharmacokinetic Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pharmacokinetic Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Oral Dissolution Testing (FDC)
Table 4. Major Players of Intravenous Titration Test (IVRT)
Table 5. Major Players of Cell Line In-house Testing (ICR)
Table 6. Pharmacokinetic Testing Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Pharmacokinetic Testing Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
Table 9. Pharmacokinetic Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Pharmacokinetic Testing Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)
Table 12. Global Pharmacokinetic Testing Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Pharmacokinetic Testing Revenue Market Share by Player (2020-2025)
Table 14. Pharmacokinetic Testing Key Players Head office and Products Offered
Table 15. Pharmacokinetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Pharmacokinetic Testing Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Pharmacokinetic Testing Market Size Market Share by Region (2020-2025)
Table 20. Global Pharmacokinetic Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Pharmacokinetic Testing Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Pharmacokinetic Testing Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Pharmacokinetic Testing Market Size Market Share by Country (2020-2025)
Table 24. Americas Pharmacokinetic Testing Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
Table 26. Americas Pharmacokinetic Testing Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)
Table 28. APAC Pharmacokinetic Testing Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Pharmacokinetic Testing Market Size Market Share by Region (2020-2025)
Table 30. APAC Pharmacokinetic Testing Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Pharmacokinetic Testing Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Pharmacokinetic Testing Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Pharmacokinetic Testing Market Size Market Share by Country (2020-2025)
Table 34. Europe Pharmacokinetic Testing Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Pharmacokinetic Testing Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Pharmacokinetic Testing Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Pharmacokinetic Testing Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Pharmacokinetic Testing Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Pharmacokinetic Testing
Table 40. Key Market Challenges & Risks of Pharmacokinetic Testing
Table 41. Key Industry Trends of Pharmacokinetic Testing
Table 42. Global Pharmacokinetic Testing Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Pharmacokinetic Testing Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Pharmacokinetic Testing Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Pharmacokinetic Testing Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pharmaceutical Product Development, LLC Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 47. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Offered
Table 48. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pharmaceutical Product Development, LLC Main Business
Table 50. Pharmaceutical Product Development, LLC Latest Developments
Table 51. Charles River Laboratories International, Inc. Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 52. Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Offered
Table 53. Charles River Laboratories International, Inc. Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Charles River Laboratories International, Inc. Main Business
Table 55. Charles River Laboratories International, Inc. Latest Developments
Table 56. Creative Bioarray Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 57. Creative Bioarray Pharmacokinetic Testing Product Offered
Table 58. Creative Bioarray Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Creative Bioarray Main Business
Table 60. Creative Bioarray Latest Developments
Table 61. Certara, L.P. Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 62. Certara, L.P. Pharmacokinetic Testing Product Offered
Table 63. Certara, L.P. Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Certara, L.P. Main Business
Table 65. Certara, L.P. Latest Developments
Table 66. Evotec AG Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 67. Evotec AG Pharmacokinetic Testing Product Offered
Table 68. Evotec AG Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Evotec AG Main Business
Table 70. Evotec AG Latest Developments
Table 71. Pacific BioLabs Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 72. Pacific BioLabs Pharmacokinetic Testing Product Offered
Table 73. Pacific BioLabs Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Pacific BioLabs Main Business
Table 75. Pacific BioLabs Latest Developments
Table 76. GVK Biosciences Private Limited Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 77. GVK Biosciences Private Limited Pharmacokinetic Testing Product Offered
Table 78. GVK Biosciences Private Limited Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. GVK Biosciences Private Limited Main Business
Table 80. GVK Biosciences Private Limited Latest Developments
Table 81. SGS SA Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 82. SGS SA Pharmacokinetic Testing Product Offered
Table 83. SGS SA Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. SGS SA Main Business
Table 85. SGS SA Latest Developments
Table 86. LGC Limited Details, Company Type, Pharmacokinetic Testing Area Served and Its Competitors
Table 87. LGC Limited Pharmacokinetic Testing Product Offered
Table 88. LGC Limited Pharmacokinetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. LGC Limited Main Business
Table 90. LGC Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Pharmacokinetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacokinetic Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pharmacokinetic Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pharmacokinetic Testing Sales Market Share by Country/Region (2024)
Figure 8. Pharmacokinetic Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pharmacokinetic Testing Market Size Market Share by Type in 2024
Figure 10. Pharmacokinetic Testing in Hospital
Figure 11. Global Pharmacokinetic Testing Market: Hospital (2020-2025) & ($ millions)
Figure 12. Pharmacokinetic Testing in Clinic
Figure 13. Global Pharmacokinetic Testing Market: Clinic (2020-2025) & ($ millions)
Figure 14. Pharmacokinetic Testing in Research Institutions
Figure 15. Global Pharmacokinetic Testing Market: Research Institutions (2020-2025) & ($ millions)
Figure 16. Global Pharmacokinetic Testing Market Size Market Share by Application in 2024
Figure 17. Global Pharmacokinetic Testing Revenue Market Share by Player in 2024
Figure 18. Global Pharmacokinetic Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas Pharmacokinetic Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC Pharmacokinetic Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe Pharmacokinetic Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Pharmacokinetic Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas Pharmacokinetic Testing Value Market Share by Country in 2024
Figure 24. United States Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Pharmacokinetic Testing Market Size Market Share by Region in 2024
Figure 29. APAC Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
Figure 30. APAC Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)
Figure 31. China Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Pharmacokinetic Testing Market Size Market Share by Country in 2024
Figure 38. Europe Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
Figure 39. Europe Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 41. France Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Pharmacokinetic Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Pharmacokinetic Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 57. United States Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 61. China Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 65. India Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 68. France Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 69. UK Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 75. Turkey Pharmacokinetic Testing Market Size 2026-2031 ($ millions)
Figure 76. Global Pharmacokinetic Testing Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Pharmacokinetic Testing Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Pharmacokinetic Testing Market Size 2026-2031 ($ millions)